Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlus500 Regulatory News (PLUS)

Share Price Information for Plus500 (PLUS)

Share Price is delayed by 15 minutes
Get Live Data
4,790.00    18.00 (0.38%)
Bid:
4,774.00
Ask:
4,778.00
Spread: 4.00 (0.084%)
Market Cap: £3.33b
PLUS Live PriceLast checked at - London Stock Exchange

Intraday Plus500 Share Chart

EGM Results

8 Jan 2024 13:18

RNS Number : 9837Y
Plus500 Limited
08 January 2024

8 January 2024

Plus500 Ltd.

("Plus500", the "Company" or together with its subsidiaries the "Group")

EGM Results

Plus500, an established global multi?asset fintech group operating proprietary technology?based trading platforms, announces the results of the resolutions proposed at today's Extraordinary General Meeting ("EGM").

The resolutions proposed were voted on by way of a poll and passed by the requisite majority. For further information, the full results of the poll are set out below:

Resolutions

For

% Votes cast

Against

% Votes cast

Vote Withheld

Total Votes Cast (excl. Votes Withheld)

% of issued share capital*

1. Elect Anne Grim

43,201,875

77.60%

12,468,756

22.40%

328,470

55,670,631

70.25%

2. Elect Tami Gottlieb

43,909,511

78.47%

12,046,793

21.53%

42,797

55,956,304

70.61%

3. Elect Daniel King

40,589,936

75.24%

13,353,777

24.76%

2,055,388

53,943,713

68.07%

To view the full wording of, and the votes required for, each of the resolutions, please refer to the Notice of Extraordinary General Meeting which is available on the Company's website.

Votes withheld are not a vote in law and have not been counted in the calculation of the votes for and against the resolution, the total votes validly cast or the calculation of the proportion of issued share capital voted.

The Board of Plus500 notes that more than 20% votes were cast against the Board's recommendation for the resolutions, and therefore intends to engage with shareholders and shareholder advisory bodies to better understand their views in this regard. In accordance with the UK Corporate Governance Code, an update on the views received from shareholders and the actions taken will be published by Plus500 during the next six months.

Listing Rule 9.6.2 and total voting rights

In accordance with Listing Rule 9.6.2, a copy of the resolutions that were passed at the Extraordinary General Meeting, which do not constitute ordinary business, will shortly be available for inspection via the National Storage Mechanism:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

*As at 8 December 2023, the day on which shareholders were required to be on the register in order to be eligible to vote, the number of Ordinary Shares of NIS 0.01 in issue, entitling the holders to vote on all the resolutions at the EGM, was 79,246,519 (excluding treasury shares), and the Company held 35,641,858 Ordinary Shares in treasury.

The voting poll results are available on the Company's website at www.plus500.com.

For further details:

Plus500 Ltd.

Elad Even-Chen, Chief Financial Officer

Owen Jones, Head of Investor Relations

+972 4 8189503

+44 (0) 7551 654208

ir@Plus500.com

Dentons Global Advisors

James Melville-Ross

James Styles

Methuselah Tanyanyiwa

+44 (0)20 7664 5095

Plus500@dentonsglobaladvisors.com

About Plus500

Plus500 is a global multi-asset fintech group operating proprietary technology-based trading platforms. Plus500 offers customers a range of trading products, including OTC ("Over-the-Counter" products, namely Contracts for Difference (CFDs)), share dealing, as well as futures and options on futures.

The Group retains operating licences and is regulated in the United Kingdom, Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, the Seychelles, the United States, Estonia, Japan, the UAE and the Bahamas and through its OTC product portfolio, offers more than 2,500 different underlying global financial instruments, comprising equities, indices, commodities, options, ETFs, foreign exchange and cryptocurrencies. Customers of the Group can trade its OTC products in more than 50 countries and in 30 languages.

Plus500's trading platforms are accessible from multiple operating systems (iOS, Android and Windows) and web browsers. Customer care is, and has always been, integral to Plus500. As such, OTC customers cannot be subject to negative balances. A free demo account is available on an unlimited basis for OTC trading platform users and sophisticated risk management tools are provided free of charge to manage leveraged exposure, and stop losses to help customers protect profits, while limiting capital losses.

Plus500 shares have a premium listing on the Main Market of the London Stock Exchange (symbol: PLUS) and are a constituent of the FTSE 250 index. www.plus500.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ROMQKFBDNBKDPDK
Date   Source Headline
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20254:11 pmRNSHolding(s) in Company
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSDirector/PDMR Shareholding
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20252:01 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSHalf Year 2025 Trading Update
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSDirector/PDMR Shareholding
23rd Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSNotification under UK Listing Rule 9.6.14(2)
23rd Jun 20257:00 amRNSPlus500 secures a new regulatory licence in Canada
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSHolding(s) in Company
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.